Method for treating non-melanoma skin cancer by inducing UDP-glucuronosyltransferase activity using pterostilbene
US10039725B2 · kind B2 · utility
0Cited by
3References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 22, 2014 |
| Grant date | Aug 7, 2018 |
| Priority date | — |
| Expiry date | Dec 19, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is provided for treating an individual for a cellular proliferative disorder, including administering to the individual in need of such treatment a therapeutically effective amount of the compound pterostilbene wherein UDP-glucuronosyltransferase (UGT) activity is increased. In an embodiment, 12-HETE levels can be reduced by administration of pterostilbene.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.